To learn more about our Abuse-Deterrence capabilities, please complete the form to the right.


One of our nation’s current epidemics is prescription drug abuse. In an effort to control this epidemic the FDA has recently updated their guidelines on opioid formulations to now employ strategies to reduce or eliminate the potential for abuse and misuse.  

The FDA now requires that a scientifically rigorous laboratory-based in-vitro manipulation and extraction study be performed to evaluate how easily said product may be abused or comprised. 

Benefits of Using Our Service:

  • Excellent reputation for responsiveness, problem solving, and reliable outcomes
  • cGMP compliant with robust quality systems.
  • Exemplary compliance record
  • Experienced Project Management team ensures scope and timeline are communicated and achieved

Download the Alcami Abuse Deterrence Overview